Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
=================================================================================================================================================================================

* I. Puzanov
* A. Diab
* K. Abdallah
* C. O. Bingham III
* C. Brogdon
* R. Dadu
* L. Hamad
* S. Kim
* M. E. Lacouture
* N. R. LeBoeuf
* D. Lenihan
* C. Onofrei
* V. Shannon
* R. Sharma
* A. W. Silk
* D. Skondra
* M. E. Suarez-Almazor
* Y. Wang
* K. Wiley
* H. L. Kaufman
* M. S. Ernstoff
* on behalf of the Society for Immunotherapy of Cancer Toxicity Management Working Group
* Jeff Anderson
* Deborah Arrindell
* Stephanie Andrews
* Joan Ballesteros
* Janie Boyer
* Daniel Chen
* David Chonzi
* Ion Cotarla
* Renato Cunha
* Marianne Davies
* Michelle Dawson
* Adam Dicker
* Lisa Eifler
* Andrew Ferguson
* Cristiano Ferlini
* Stanley Frankel
* William Go
* Celestine Gochett
* Jenna Goldberg
* Priscila Goncalves
* Trishna Goswami
* Nancy Gregory
* James L. Gulley
* Vinny Hayreh
* Nicole Helie
* William Holmes
* Jer-Yuan Hsu
* Ramy Ibrahim
* Cecilia Larocca
* Kimberly Lehman
* Sergio Ley-Acosta
* Olivier Lambotte
* Jason Luke
* Joan McClure
* Elisabete Michelon
* Mary Nakamura
* Kiran Patel
* Bilal Piperdi
* Zeshaan Rasheed
* Dan Reshef
* Joanne Riemer
* Caroline Robert
* Makan Sarkeshik
* Ann Saylors
* Judy Schreiber
* Kim Shafer-Weaver
* William Sharfman
* Elad Sharon
* Richard Sherry
* Cyndy Simonson
* Cherry Thomas
* John A. Thompson
* Elizabeth Trehu
* Dina Tresnan
* Michelle Turner
* Darshan Wariabharaj
* Ian Waxman
* Lauren Wood
* Lin Zhang
* Pan Zheng